{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:03:40Z","timestamp":1784099020592,"version":"3.55.0"},"reference-count":204,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Galectins, a structurally conserved family of \u03b2-galactoside-binding lectins, have emerged as key regulators of cancer progression. However, their integrated roles across tumor immunity, metabolic rewiring, and metastasis have yet to be fully defined. In this review, we synthesize current evidence on major galectin family members, particularly galectin (Gal)-1, Gal-3, Gal-4, Gal-7, Gal-9, and Gal-13, and delineate how they drive tumor progression through mechanistically distinct yet convergent pathways. Specifically, galectins induce T-cell dysfunction through T-cell immunoglobulin and mucin-domain containing-3 (TIM-3)- and programmed cell death protein 1 (PD-1)-associated signaling, reprogram macrophages and myeloid-derived suppressor cells (MDSCs) via phosphoinositide 3-kinase\/protein kinase B (PI3K\/AKT), Janus kinase\/signal transducer and activator of transcription (JAK\/STAT), and nuclear factor kappa B (NF-\u03baB) pathways, and modulate innate immune effectors, including natural killer (NK) cells, neutrophils, and dendritic cells, in a context-dependent manner. Beyond immune regulation, galectins reshape tumor metabolism through effects on glycolysis, lipid metabolism, and glycan remodeling, and differentially regulate ferroptosis susceptibility, with the contrasting roles of Gal-1 and Gal-13 underscoring functional diversity within the family. Emerging evidence further implicates galectins in resistance to chemotherapy, targeted therapy, immune checkpoint blockade, and chimeric antigen receptor T-cell (CAR-T) therapy, positioning them as candidate therapeutic targets. We also discuss galectin-directed strategies, including small-molecule inhibitors, nanomedicine-based platforms, vaccination approaches, and rational combination therapies, and highlight the promise of multi-galectin biomarker panels for precision oncology.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1849406","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:04:42Z","timestamp":1784095482000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Galectins at the crossroads of tumor immunity, metabolism, and metastasis: mechanisms, therapeutic resistance, and translational opportunities"],"prefix":"10.3389","volume":"17","author":[{"given":"Chengxun","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Otolaryngology, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihang","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3390\/cancers12040935","article-title":"Future challenges in cancer resistance to immunotherapy","volume":"12","author":"van Elsas","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s10238-025-01944-0","article-title":"Tumor microenvironment-mediated immune evasion and resistance in prostate cancer: mechanisms, cross-talk, and therapeutic opportunities","volume":"26","author":"Li","year":"2025","journal-title":"Clin Exp Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-20-0264","article-title":"Glycans as immune checkpoints: Removal of branched N-glycans enhances immune recognition preventing cancer progression","volume":"8","author":"Silva","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012391","article-title":"Tumor glyco-immunology, glyco-immune checkpoints and immunotherapy","volume":"13","author":"Pinho","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2016.03.021","article-title":"Shaping the immune landscape in cancer by galectin-driven regulatory pathways","volume":"428","author":"Rabinovich","year":"2016","journal-title":"J Mol Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.09.118","article-title":"Roles of galectin-3 in metabolic disorders and tumor cell metabolism","volume":"142","author":"Li","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3390\/biomedicines9091159","article-title":"Galectins in cancer and the microenvironment: Functional roles, therapeutic developments, and perspectives","volume":"9","author":"Li","year":"2021","journal-title":"Biomedicines"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.208884","article-title":"Galectins at a glance","volume":"131","author":"Johannes","year":"2018","journal-title":"J Cell Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-4614-0106-3_2","article-title":"Galectins as pattern recognition receptors: structure, function, and evolution","volume":"946","author":"Vasta","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602493","article-title":"Galectin-1 as a potential cancer target","volume":"92","author":"Rabinovich","year":"2005","journal-title":"Br J Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105400","article-title":"The universe of galectin-binding partners and their functions in health and disease","volume":"299","author":"Troncoso","year":"2023","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/biom10050750","article-title":"Galectins as checkpoints of the immune system in cancers, their clinical relevance, and implication in clinical trials","volume":"10","author":"Compagno","year":"2020","journal-title":"Biomolecules"},{"key":"B14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00281-025-01047-8","article-title":"The sweet and the bitter sides of galectin-1 in immunity: its role in immune cell functions, apoptosis, and immunotherapies for cancer with a focus on T cells","volume":"47","author":"Nov\u00e1k","year":"2025","journal-title":"Semin Immunopathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-13-3013","article-title":"Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation","volume":"74","author":"Mart\u00ednez-Bosch","year":"2014","journal-title":"Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/or.2020.7777","article-title":"Roles of galectin-3 in the tumor microenvironment and tumor metabolism (Review)","volume":"44","author":"Guo","year":"2020","journal-title":"Oncol Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwu062","article-title":"Galectin-1 links tumor hypoxia and radiotherapy","volume":"24","author":"Kuo","year":"2014","journal-title":"Glycobiology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182041","article-title":"Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression","volume":"217","author":"Girotti","year":"2020","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102612","article-title":"Galectin-7 as a biomarker for aggressiveness and poor prognosis in thymic epithelial tumors","volume":"63","author":"Lv","year":"2026","journal-title":"Transl Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4137\/cmo.S29462","article-title":"Galectin-3 as a potential target to prevent cancer metastasis","volume":"9","author":"Ahmed","year":"2015","journal-title":"Clin Med Insights Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101702","article-title":"Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative phosphorylation","volume":"12","author":"Wu","year":"2025","journal-title":"Genes Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2021-0075","article-title":"Galectin-9 and PD-L1 antibody blockade combination therapy inhibits tumour progression in pancreatic cancer","volume":"15","author":"Li","year":"2023","journal-title":"Immunotherapy"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-1995-x","article-title":"IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma","volume":"66","author":"Melief","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408788","article-title":"Galectin-1-induced tumor associated macrophages repress antitumor immunity in hepatocellular carcinoma through recruitment of Tregs","volume":"12","author":"Yu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41419-023-05897-8","article-title":"Microglial Galectin3 enhances endothelial metabolism and promotes pathological angiogenesis via Notch inhibition by competitively binding to Jag1","volume":"14","author":"Zhou","year":"2023","journal-title":"Cell Death Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.09.060","article-title":"Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue","volume":"375","author":"Nagae","year":"2008","journal-title":"J Mol Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-025-00759-1","article-title":"Multifaceted roles of galectins: from carbohydrate binding to targeted cancer therapy","volume":"13","author":"Zhang","year":"2025","journal-title":"biomark Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/biom15071028","article-title":"Galectin-3: Integrator of signaling via hexosamine flux","volume":"15","author":"Mukherjee","year":"2025","journal-title":"Biomolecules"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt5859","article-title":"Galectin-3 induces neurodevelopmental apical-basal polarity and regulates gyrification","volume":"11","author":"Soares","year":"2025","journal-title":"Sci Adv"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-024-01010-z","article-title":"Intracellular galectin interactions in health and disease","volume":"46","author":"Jacob","year":"2024","journal-title":"Semin Immunopathol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/biom10091232","article-title":"Galectins in intra- and extracellular vesicles","volume":"10","author":"B\u00e4nfer","year":"2020","journal-title":"Biomolecules"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020430","article-title":"Role of galectins in tumors and in clinical immunotherapy","volume":"19","author":"Chou","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121909","article-title":"Expression, regulation, and functions of the galectin-16 gene in human cells and tissues","volume":"11","author":"Kaminker","year":"2021","journal-title":"Biomolecules"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1042\/bj2610847","article-title":"The sequence of the mouse 14 kDa beta-galactoside-binding lectin and evidence for its synthesis on free cytoplasmic ribosomes","volume":"261","author":"Wilson","year":"1989","journal-title":"Biochem J"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.033332","article-title":"Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier","volume":"284","author":"Arg\u00fceso","year":"2009","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.661272","article-title":"Impact of exogenous galectin-9 on human T cells: Contribution of the T cell receptor complex to antigen-independent activation but not to apoptosis induction","volume":"290","author":"Lhuillier","year":"2015","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2011.09.003","article-title":"Galectin-3--a jack-of-all-trades in cancer","volume":"313","author":"Newlaczyl","year":"2011","journal-title":"Cancer Lett"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M803634200","article-title":"Galectin-3 regulates integrin alpha2beta1-mediated adhesion to collagen-I and -IV","volume":"283","author":"Friedrichs","year":"2008","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2024.101926","article-title":"Decoding the multifaceted roles of galectins in self-defense","volume":"77","author":"Sato","year":"2025","journal-title":"Semin Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2025.101974","article-title":"An evolutionary perspective of the roles of galectins in pathogen recognition and immunity","volume":"79","author":"Vasta","year":"2025","journal-title":"Semin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.731026","article-title":"Full-length galectin-3 is required for high affinity microbial interactions and antimicrobial activity","volume":"12","author":"Wu","year":"2021","journal-title":"Front Microbiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1772","article-title":"Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10","volume":"10","author":"Ilarregui","year":"2009","journal-title":"Nat Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107638","article-title":"Modulation of galectin-9 mediated responses in monocytes and T-cells by pregnancy-specific glycoprotein 1","volume":"300","author":"Mendoza","year":"2024","journal-title":"J Biol Chem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1600792","article-title":"Galectin-9 and Tim-3 in gastric cancer: a checkpoint axis driving T cell exhaustion and Treg-mediated immunosuppression independently of anti-PD-1 blockade","volume":"16","author":"Hill","year":"2025","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2014.107","article-title":"Regulation of osteoclastogenesis through Tim-3: possible involvement of the Tim-3\/galectin-9 system in the modulation of inflammatory bone destruction","volume":"94","author":"Moriyama","year":"2014","journal-title":"Lab Invest"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/biom11091386","article-title":"Galectins in endothelial cell biology and angiogenesis: The basics","volume":"11","author":"Thijssen","year":"2021","journal-title":"Biomolecules"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2020.53.4.020","article-title":"Non-classical role of galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner","volume":"53","author":"Kim","year":"2020","journal-title":"BMB Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"9992","DOI":"10.18632\/oncotarget.2486","article-title":"Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells","volume":"5","author":"Harazono","year":"2014","journal-title":"Oncotarget"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2009.10.003","article-title":"Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1","volume":"127","author":"Kov\u00e1cs-S\u00f3lyom","year":"2010","journal-title":"Immunol Lett"},{"key":"B51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41389-020-00248-0","article-title":"Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation","volume":"9","author":"Zhang","year":"2020","journal-title":"Oncogenesis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1172\/jci129025","article-title":"Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance","volume":"129","author":"Nambiar","year":"2019","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102950118","article-title":"Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8(+) regulatory T cells","volume":"118","author":"Cagnoni","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007286","article-title":"KLF12 overcomes anti-PD-1 resistance by reducing galectin-1 in cancer cells","volume":"11","author":"Zheng","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.741820","article-title":"Autophagy drives galectin-1 secretion from tumor-associated macrophages facilitating hepatocellular carcinoma progression","volume":"9","author":"Davuluri","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106984","article-title":"Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1","volume":"26","author":"Rudjord-Levann","year":"2023","journal-title":"iScience"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.7150\/thno.88917","article-title":"Comprehensive characterization of early-programmed tumor microenvironment by tumor-associated macrophages reveals galectin-1 as an immune modulatory target in breast cancer","volume":"14","author":"Chung","year":"2024","journal-title":"Theranostics"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-0046","article-title":"Galectin-1 mediates chronic STING activation in tumors to promote metastasis through MDSC recruitment","volume":"83","author":"Nambiar","year":"2023","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8488","article-title":"Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2\/kynurenine axis","volume":"7","author":"Hsu","year":"2016","journal-title":"Oncotarget"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2021.1939601","article-title":"A novel miR1983-TLR7-IFN\u03b2 circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1","volume":"10","author":"Shah","year":"2021","journal-title":"Oncoimmunology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13046-024-03124-6","article-title":"Galectin-3 induces pathogenic immunosuppressive macrophages through interaction with TREM2 in lung cancer","volume":"43","author":"Wang","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216879","article-title":"Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth","volume":"591","author":"Rivera-Ramos","year":"2024","journal-title":"Cancer Lett"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114113","article-title":"Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression","volume":"178","author":"Wang","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.01.017","article-title":"Galectin-3 accelerates M2 macrophage infiltration and angiogenesis in tumors","volume":"182","author":"Jia","year":"2013","journal-title":"Am J Pathol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/ccs3.12060","article-title":"M2-polarized tumor-associated macrophage-secreted exosomal lncRNA NEAT1 upregulates galectin-3 by recruiting KLF5 and promotes HCC immune escape","volume":"19","author":"Yuan","year":"2025","journal-title":"J Cell Commun Signal"},{"key":"B66","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13048-024-01430-3","article-title":"Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated \u03b2-catenin activation","volume":"17","author":"Wang","year":"2024","journal-title":"J Ovarian Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.143683","article-title":"Galectin-3 suppresses CD8(+) T cells function via myeloid-derived suppressor cells recruitment in cervical cancer","volume":"311","author":"Mai","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1506236","article-title":"Elevated galectin-3 levels in the tumor microenvironment of ovarian cancer - implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils","volume":"15","author":"Karlsson","year":"2024","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.06.040","article-title":"Galectin-4 potentiates CD8+ T cell immunity by enhancing MHC-I expression on dendritic cells","volume":"33","author":"Lee","year":"2025","journal-title":"Mol Ther"},{"key":"B70","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12967-025-07598-6","article-title":"The TP53-LGALS4 axis modulates the tumor immune microenvironment and synergizes with anti PD-L1 therapy in colorectal cancer","volume":"24","author":"Zhang","year":"2025","journal-title":"J Transl Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"6625","DOI":"10.1038\/s41598-024-57162-3","article-title":"Galectin 7 leads to a relative reduction in CD4+\u2009T cells, mediated by PD-1","volume":"14","author":"Wu","year":"2024","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.22034\/apjcp.2017.18.8.2269","article-title":"Upregulation of galectin-9 and PD-L1 immune checkpoints molecules in patients with chronic lymphocytic leukemia","volume":"18","author":"Taghiloo","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146735","article-title":"TIM-3\/Galectin-9 immune axis in colorectal cancer in relation to KRAS, NRAS, BRAF, PIK3CA, AKT1 mutations, MSI status, and the cytokine milieu","volume":"26","author":"Ochman","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X2023e12370","article-title":"Increased tumor-associated mast cells facilitate thyroid cancer progression by inhibiting CD8+ T cell function through galectin-9","volume":"56","author":"Hou","year":"2023","journal-title":"Braz J Med Biol Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/cas.70232","article-title":"The LGALS9\/miR-491-5p axis regulates CD8(+) T cell function and inhibits the progression of gastric cancer","volume":"117","author":"Huang","year":"2026","journal-title":"Cancer Sci"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005714","article-title":"T lymphocytes induce human cancer cells derived from solid Malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins","volume":"11","author":"Schlichtner","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001849","article-title":"Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors","volume":"8","author":"Okoye","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1273309","article-title":"PD-L1, galectin-9 and CD8(+) tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma","volume":"6","author":"Sideras","year":"2017","journal-title":"Oncoimmunology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.800928","article-title":"Galectin-9\/TIM-3 as a key regulator of immune response in gliomas with chromosome 1p\/19q codeletion","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01253-8","article-title":"Cell-associated galectin 9 interacts with cytotoxic T cells confers resistance to tumor killing in nasopharyngeal carcinoma through autophagy activation","volume":"22","author":"Kam","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2025.09.006","article-title":"Galectin-9 promotes colon cancer development by polarizing macrophages toward the M2 phenotype","author":"Zhang","year":"2025","journal-title":"Cancer Genet"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02429-2","article-title":"Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response","volume":"68","author":"Qi","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1097\/cmr.0000000000000281","article-title":"Galectin-9 modulates immunity by promoting Th2\/M2 differentiation and impacts survival in patients with metastatic melanoma","volume":"26","author":"Enninga","year":"2016","journal-title":"Melanoma Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12390","article-title":"Extracellular vesicles derived from nasopharyngeal carcinoma induce the emergence of mature regulatory dendritic cells using a galectin-9 dependent mechanism","volume":"12","author":"Lefebvre","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010066","article-title":"Galectin-9 triggers neutrophil-mediated anticancer immunity","volume":"10","author":"Ustyanovska Avtenyuk","year":"2021","journal-title":"Biomedicines"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1733688","article-title":"Interrogation of glioma immune microenvironment identifies a non-canonical role for microglial galectin-9 in tumor cell adhesion and phagocytosis","volume":"17","author":"Gupta","year":"2026","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-3878","article-title":"Galectin-9 mediates the functions of microglia in the hypoxic brain tumor microenvironment","volume":"84","author":"Lee","year":"2024","journal-title":"Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-22-0970","article-title":"Inhibition of melanoma cell-intrinsic Tim-3 stimulates MAPK-dependent tumorigenesis","volume":"82","author":"Schatton","year":"2022","journal-title":"Cancer Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1172\/jci167728","article-title":"CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion","volume":"133","author":"Wang","year":"2023","journal-title":"J Clin Invest"},{"key":"B90","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41416-025-03241-9","article-title":"Galectin-9-driven immunosuppressive macrophage population shapes the lymph node metastatic microenvironment","volume":"134","author":"Zhou","year":"2026","journal-title":"Br J Cancer"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00838-3","article-title":"miR-22-galectin-1 as an integral signaling axis in regulating metabolism and immunity in HCC","volume":"14","author":"Hu","year":"2026","journal-title":"biomark Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204867","article-title":"Galectin-1-mediated MET\/AXL signaling enhances sorafenib resistance in hepatocellular carcinoma by escaping ferroptosis","volume":"15","author":"Hsu","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157416","article-title":"Dihydroartemisinin inhibits galectin-1-induced ferroptosis resistance and peritoneal metastasis of gastric cancer via the Nrf2-HO-1 pathway","volume":"148","author":"Ding","year":"2025","journal-title":"Phytomedicine"},{"key":"B94","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41419-024-06865-6","article-title":"A novel LGALS1-depended and immune-associated fatty acid metabolism risk model in acute myeloid leukemia stem cells","volume":"15","author":"Qin","year":"2024","journal-title":"Cell Death Dis"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.120608","article-title":"Galectin-1 induces macrophage immunometabolic reprogramming, modulates T cell immunity and attenuates atherosclerotic plaque formation","volume":"413","author":"Li","year":"2026","journal-title":"Atherosclerosis"},{"key":"B96","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3892\/ol.2025.14873","article-title":"LGALS4 inhibits glycolysis and promotes apoptosis of colorectal cancer cells via \u03b2-catenin signaling","volume":"29","author":"Li","year":"2025","journal-title":"Oncol Lett"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512305","article-title":"Galectin-4 is involved in the structural changes of glycosphingolipid glycans in poorly differentiated gastric cancer cells with high metastatic potential","volume":"24","author":"Hachisu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70661","article-title":"Myeloid-derived LGALS9-P4HB immune interaction promotes metastasis in gastric cancer through enhanced cell proliferation and lipid metabolism","volume":"29","author":"Zhu","year":"2025","journal-title":"J Cell Mol Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-025-01888-2","article-title":"Galectin-13 reduces membrane localization of SLC7A11 for ferroptosis propagation","volume":"21","author":"Zhang","year":"2025","journal-title":"Nat Chem Biol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwz081","article-title":"Galectin-13\/placental protein 13: redox-active disulfides as switches for regulating structure, function and cellular distribution","volume":"30","author":"Yang","year":"2020","journal-title":"Glycobiology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001391","article-title":"Galectin-1 modulates glycolysis through a GM1-galactose-dependent pathway to promote hyperthermia resistance in HCC","volume":"83","author":"Nguyen","year":"2026","journal-title":"Hepatology"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.324","article-title":"Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK\/PI3K\/AKT signaling","volume":"7","author":"Zhang","year":"2016","journal-title":"Cell Death Dis"},{"key":"B103","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13046-016-0449-1","article-title":"Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through \u03b21 integrin-mediated upregulation of Gli1 in gastric cancer","volume":"35","author":"Chong","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203295","article-title":"Fibroblastic galectin-1-fostered invasion and metastasis are mediated by TGF-\u03b21-induced epithelial-mesenchymal transition in gastric cancer","volume":"13","author":"You","year":"2021","journal-title":"Aging (Albany Ny)"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/cells14040310","article-title":"Therapeutic targeting of the Galectin-1\/miR-22-3p axis regulates cell cycle and EMT depending on the molecular subtype of breast cancer","volume":"14","author":"Kim","year":"2025","journal-title":"Cells"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117399","article-title":"Pharmacological inhibition of JNK-MAPK disrupts cigarette smoke-induced RUNX2\/Galectin-3 -driven EMT and cancer stemness in lung adenocarcinoma cells","volume":"242","author":"Chhetri","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14202270","article-title":"Is immunohistochemical Galectin-3 expression associated with the epithelial-mesenchymal transition in high- and low-grade invasive urothelial carcinomas of the bladder","volume":"14","author":"Cin","year":"2024","journal-title":"Diagn (Basel)"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-11-1462","article-title":"Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium","volume":"17","author":"Barrow","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.979474","article-title":"Circulating galectin-3 promotes tumor-endothelium-adhesion by upregulating ICAM-1 in endothelium-derived extracellular vesicles","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002649","article-title":"Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3","volume":"135","author":"Mammadova-Bach","year":"2020","journal-title":"Blood"},{"key":"B111","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.canlet.2019.11.002","article-title":"RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1","volume":"469","author":"Wu","year":"2020","journal-title":"Cancer Lett"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13016","article-title":"Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway","volume":"107","author":"Shen","year":"2016","journal-title":"Cancer Sci"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2015.77","article-title":"Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation","volume":"95","author":"Serizawa","year":"2015","journal-title":"Lab Invest"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.1c00902","article-title":"Galectin-9 signaling drives breast cancer invasion through extracellular matrix","volume":"17","author":"Pally","year":"2022","journal-title":"ACS Chem Biol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-25-0252","article-title":"TRIM49 deficiency stabilizes a Galectin-3\/EGR1 transcriptional complex that drives invasiveness of gastric adenocarcinoma","volume":"86","author":"Qin","year":"2026","journal-title":"Cancer Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/med.22041","article-title":"Galectin-8 inhibition and functions in immune response and tumor biology","volume":"44","author":"Puri\u0107","year":"2024","journal-title":"Med Res Rev"},{"key":"B117","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.1038\/s41598-020-64371-z","article-title":"The animal lectin Galectin-8 promotes cytokine expression and metastatic tumor growth in mice","volume":"10","author":"Shatz-Azoulay","year":"2020","journal-title":"Sci Rep"},{"key":"B118","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-22802-5","article-title":"Galectin-8 alters immune microenvironment and promotes tumor progression","volume":"13","author":"Wang","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1722434115","article-title":"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk","volume":"115","author":"Orozco","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B120","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/2326-6066.Cir-21-1088","article-title":"Extracellular Galectin 4 drives immune evasion and promotes T-cell apoptosis in pancreatic cancer","volume":"11","author":"Lidstr\u00f6m","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B121","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/s12885-023-11047-2","article-title":"Galectin-1 promotes gastric cancer peritoneal metastasis through peritoneal fibrosis","volume":"23","author":"Shen","year":"2023","journal-title":"BMC Cancer"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2022.5431","article-title":"Galectin-1 binds GRP78 to promote the proliferation and metastasis of gastric cancer","volume":"61","author":"Zhang","year":"2022","journal-title":"Int J Oncol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111564","article-title":"Exosomal Galectin-3 promotes peritoneal metastases in gastric adenocarcinoma via microenvironment alterations","volume":"28","author":"Fan","year":"2025","journal-title":"iScience"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-023-01366-5","article-title":"Suppression of galectin-4 attenuates peritoneal metastasis of poorly differentiated gastric cancer cells","volume":"26","author":"Ideo","year":"2023","journal-title":"Gastric Cancer"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03247-2","article-title":"LGALS9B stabilizes EEF1D protein and activates the PI3K\/AKT signaling pathway to promote gastric cancer occurrence and metastasis","volume":"44","author":"Feng","year":"2025","journal-title":"Oncogene"},{"key":"B126","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-022-04520-6","article-title":"Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression","volume":"13","author":"Carabias","year":"2022","journal-title":"Cell Death Dis"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030351","article-title":"Inhibition of Galectin-1 and androgen receptor axis enhances enzalutamide treatment in enzalutamide resistant prostate cancer","volume":"17","author":"Wang","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-2241","article-title":"Targeting Galectin-1 overcomes paclitaxel resistance in esophageal squamous cell carcinoma","volume":"84","author":"Zhou","year":"2024","journal-title":"Cancer Res"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.5230\/jgc.2024.24.e25","article-title":"Galectin-1 promotes gastric carcinoma progression and cisplatin resistance through the NRP-1\/c-JUN\/Wee1 pathway","volume":"24","author":"Pan","year":"2024","journal-title":"J Gastric Cancer"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102313","article-title":"SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467\/Gal-1 signaling pathway in epithelial ovarian carcinoma","volume":"11","author":"Zhang","year":"2019","journal-title":"Aging (Albany Ny)"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336918.2024.2335881","article-title":"Galectin-1 overexpression induces normal fibroblasts translate into cancer-associated fibroblasts and attenuates the sensitivity of anlotinib in lung cancer","volume":"18","author":"Zhang","year":"2024","journal-title":"Cell Adh Migr"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14474","article-title":"Galectin-3 enhances trastuzumab resistance by regulating cancer Malignancy and stemness in HER2-positive breast cancer cells","volume":"13","author":"Chen","year":"2022","journal-title":"Thorac Cancer"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814402","article-title":"Knockdown of BAP31 downregulates Galectin-3 to inhibit the Wnt\/\u03b2-catenin signaling pathway to modulate 5-FU chemosensitivity and cancer stemness in colorectal cancer","volume":"24","author":"Liu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121505","article-title":"Galectin-3 is a key hepatoprotective molecule against the deleterious effect of cisplatin","volume":"318","author":"Santos","year":"2023","journal-title":"Life Sci"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3549","article-title":"DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3\/PI3k\/Akt pathway","volume":"38","author":"Ma","year":"2020","journal-title":"Cell Biochem Funct"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115834","article-title":"Galectin-7 promotes cisplatin efficacy by facilitating apoptosis and G3BP1 degradation in cervical cancer","volume":"217","author":"Liu","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41420-023-01515-w","article-title":"Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance","volume":"9","author":"Choukrani","year":"2023","journal-title":"Cell Death Discov"},{"key":"B138","doi-asserted-by":"publisher","first-page":"45305","DOI":"10.1038\/s41598-025-29173-1","article-title":"The relationship between galectin-1 expression and the efficacy of anti-PD-1 therapy for non-small cell lung cancer patients","volume":"15","author":"Tone","year":"2025","journal-title":"Sci Rep"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7113","article-title":"Effect of galectin-1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma","volume":"13","author":"Wang","year":"2024","journal-title":"Cancer Med"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/s1535-6108(04)00024-8","article-title":"Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; a potential mechanism of tumor-immune privilege","volume":"5","author":"Rubinstein","year":"2004","journal-title":"Cancer Cell"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04832-x","article-title":"Myeloid leukemia-derived galectin-1 downregulates CAR expression to hinder cytotoxicity of CAR T cells","volume":"22","author":"Li","year":"2024","journal-title":"J Transl Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1250559","article-title":"Resistance to anti-PD-1\/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1\/PD-L1","volume":"14","author":"Mabbitt","year":"2023","journal-title":"Front Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002371","article-title":"Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor","volume":"9","author":"Curti","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B144","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.12032","article-title":"Effect of anti CTLA-4 and PD-1 monoclonal antibodies on systemic SDF-1 and galectin-3 levels through NLRP3 and MyD-88 pathways in preclinical models","volume-title":"American Society of Clinical Oncology","author":"Iovine","year":"2024"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-336374","article-title":"Galectin-4 drives anti-PD-L1\/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma","volume":"75","author":"Xu","year":"2025","journal-title":"Gut"},{"key":"B146","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1182\/blood-2019-131680","article-title":"Galectin-9 from bone marrow mesenchymal stromal cells mediates immunosuppression on chimeric antigen receptor T cells","volume":"134","author":"Teng","year":"2019","journal-title":"Blood"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-18-2244","article-title":"An orally active Galectin-3 antagonist inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade","volume":"79","author":"Vuong","year":"2019","journal-title":"Cancer Res"},{"key":"B148","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s10020-025-01356-6","article-title":"Targeting galectin-3 in cancer by novel and unique inhibitors of non-carbohydrate origin","volume":"31","author":"Sindrewicz-Goral","year":"2025","journal-title":"Mol Med"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2024.153786","article-title":"Effect of modified citrus pectin on galectin-3 inhibition in cisplatin-induced cardiac and renal toxicity","volume":"504","author":"Santos","year":"2024","journal-title":"Toxicology"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5583491","article-title":"Galectin-3 inhibitors suppress anoikis resistance and invasive capacity in thyroid cancer cells","volume":"2021","author":"Lee","year":"2021","journal-title":"Int J Endocrinol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"15287","DOI":"10.1038\/s41598-024-64781-3","article-title":"Bergenin inhibits growth of human cervical cancer cells by decreasing galectin-3 and MMP-9 expression","volume":"14","author":"Chauhan","year":"2024","journal-title":"Sci Rep"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24516","article-title":"Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy","volume":"9","author":"Bustos","year":"2018","journal-title":"Oncotarget"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S503381","article-title":"Selective glycopolymer inhibitors of galectin-3: Supportive anti-cancer agents protecting monocytes and preserving interferon-gamma function","volume":"20","author":"Filipov\u00e1","year":"2025","journal-title":"Int J Nanomed"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189228","article-title":"Inhibitory effect of fucoidan analogs on highly metastatic gastric cancer cells via galectin-4 inhibition","volume":"26","author":"Ji","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.79163","article-title":"Inhibition of JNK\/c-Jun-ATF2 overcomes cisplatin resistance in liver cancer through down-regulating galectin-1","volume":"19","author":"Yang","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.117069","article-title":"Ganoderic acid T, a Ganoderma triterpenoid, modulates the tumor microenvironment and enhances the chemotherapy and immunotherapy efficacy through downregulating galectin-1 levels","volume":"491","author":"Chen","year":"2024","journal-title":"Toxicol Appl Pharmacol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1372956","article-title":"Improving cancer immunotherapy in prostate cancer by modulating T cell function through targeting the galectin-1","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-03139-4","article-title":"Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden","volume":"71","author":"Femel","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001535","article-title":"Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome","volume":"8","author":"Tiraboschi","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119048119","article-title":"Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis","volume":"119","author":"Choi","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2021.1892265","article-title":"Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity","volume":"10","author":"Sturgill","year":"2021","journal-title":"Oncoimmunology"},{"key":"B162","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1038\/s41598-021-82686-3","article-title":"Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16\/CA-125-expressing Malignancies","volume":"11","author":"Stasenko","year":"2021","journal-title":"Sci Rep"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2022.2026020","article-title":"Peptide vaccination activating galectin-3-specific T cells offers a novel means to target galectin-3-expressing cells in the tumor microenvironment","volume":"11","author":"Bendtsen","year":"2022","journal-title":"Oncoimmunology"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1267279","article-title":"A novel anti-galectin-9 immunotherapy limits the early progression of pancreatic neoplastic lesions in transgenic mice","volume":"14","author":"Quilbe","year":"2023","journal-title":"Front Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010926","article-title":"Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion","volume":"13","author":"Linghu","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.79852","article-title":"Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity","volume":"19","author":"Zheng","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.84108","article-title":"Inhibition of galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity","volume":"19","author":"Sun","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.1c02116","article-title":"An antibody-like polymeric nanoparticle removes intratumoral galectin-1 to enhance antitumor T-cell responses in cancer immunotherapy","volume":"13","author":"Gu","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114714","article-title":"Galectin-1-targeted theranostic nanoprobe for multimodal imaging and photothermal therapy in cervical cancer lymph node metastases","volume":"253","author":"Duan","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"B170","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/nsa.S448883","article-title":"Spectroscopic assessment of doxorubicin (DOX)-gemcitabine (GEM) gold complex nanovector as diagnostic tool of galectin-1 biomarker","volume":"17","author":"Khan","year":"2024","journal-title":"Nanotechnol Sci Appl"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.12.028","article-title":"Development of galectin-3 targeted radioimmunoligands for cancer theranostics","author":"Zhang","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"B172","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s42003-024-05891-6","article-title":"Tumor-targeted nanodrug FSGG\/siGal-9 for transdermal photothermal immunotherapy of melanoma","volume":"7","author":"Ren","year":"2024","journal-title":"Commun Biol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11060-023-04257-y","article-title":"T7 peptide-decorated exosome-based nanocarrier system for delivery of galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma","volume":"162","author":"Li","year":"2023","journal-title":"J Neuro-Oncol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123511","article-title":"Nanoparticles-mediated intratumoral gene editing targeting PD-L1 and galectin-9 for improved cancer immunotherapy","volume":"324","author":"Fang","year":"2026","journal-title":"Biomaterials"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120546","article-title":"Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment","volume":"268","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.11.294","article-title":"Galectin-7 induction by EHMT2 inhibition enhances immunity in microsatellite stability colorectal cancer","volume":"166","author":"Sun","year":"2024","journal-title":"Gastroenterology"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c00071","article-title":"Development of galectin-7-specific nanobodies: Implications for immunotherapy and molecular imaging in cancer","volume":"68","author":"Nehm\u00e9","year":"2025","journal-title":"J Med Chem"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1021\/jm801077j","article-title":"Galectin-inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells","volume":"51","author":"Delaine","year":"2008","journal-title":"J Med Chem"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c00485","article-title":"Discovery of the selective and orally available Galectin-1 inhibitor GB1908 as a potential treatment for lung cancer","volume":"67","author":"Zetterberg","year":"2024","journal-title":"J Med Chem"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c03703","article-title":"An orally available halothiazole glycomimetic as a cancer-targeting dual Galectin-1 and Galectin-3 inhibitor","volume":"69","author":"Zetterberg","year":"2026","journal-title":"J Med Chem"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c01747","article-title":"Development and characterization of a high-affinity selective galectin-3 mouse tool compound in mouse models of cancer","volume":"67","author":"Peterson","year":"2024","journal-title":"J Med Chem"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.9b00396","article-title":"Epimers switch galectin-9 domain selectivity: 3N-aryl galactosides bind the C-terminal and gulosides bind the N-terminal","volume":"11","author":"Mahanti","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-023-04513-y","article-title":"Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants","volume":"91","author":"Aslanis","year":"2023","journal-title":"Cancer Chemother Pharmacol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/1878-0261.13505","article-title":"Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma","volume":"18","author":"Torres-Mart\u00ednez","year":"2024","journal-title":"Mol Oncol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266888","article-title":"Noninvasively deciphering the immunosuppressive tumor microenvironment using galectin-1 PET to inform immunotherapy responses","volume":"65","author":"Liu","year":"2024","journal-title":"J Nucl Med"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/306964","article-title":"Circulating galectin-1 and 90K\/Mac-2BP correlated with the tumor stages of patients with colorectal cancer","volume":"2015","author":"Wu","year":"2015","journal-title":"BioMed Res Int"},{"key":"B187","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13048-021-00874-1","article-title":"Galectin-1 as a predictive biomarker in ovarian cancer","volume":"14","author":"Masoodi","year":"2021","journal-title":"J Ovarian Res"},{"key":"B188","article-title":"Overexpression of galectin2 (LGALS2) predicts a better prognosis in human breast cancer","volume":"14","author":"Chetry","year":"2022","journal-title":"Am J Transl Res"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15775","article-title":"Serum galectin-3 as a biomarker for screening, early diagnosis, prognosis and therapeutic effect evaluation of pancreatic cancer","volume":"24","author":"Yi","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3390\/genes15060818","article-title":"Correlation analysis of genetic mutations and galectin levels in breast cancer patients","volume":"15","author":"Markalunas","year":"2024","journal-title":"Genes (Basel)"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071508","article-title":"Prognostic influence of galectin-1 in gastric adenocarcinoma","volume":"12","author":"D\u00edaz Del Arco","year":"2024","journal-title":"Biomedicines"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9101383","article-title":"Association of galectin 9 expression with immune cell infiltration, programmed cell death ligand-1 expression, and patient's clinical outcome in triple-negative breast cancer","volume":"9","author":"Ju","year":"2021","journal-title":"Biomedicines"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129119","article-title":"Galectin-1, -3 and -9 expression and clinical significance in squamous cervical cancer","volume":"10","author":"Punt","year":"2015","journal-title":"PloS One"},{"key":"B194","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4103\/jomfp.JOMFP_240_19","article-title":"Galectin-1 expression in oral squamous cell carcinoma: An immunohistochemical study","volume":"24","author":"Salunkhe","year":"2020","journal-title":"J Oral Maxillofac Pathol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1111\/febs.70134","article-title":"Gal-1 promotes lung cancer cell survival by enhancing PARP1\/H1.2 interaction to promote DNA repair upon DNA damage response","volume":"292","author":"Chen","year":"2025","journal-title":"FEBS J"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101117","article-title":"Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function","volume":"60","author":"Raiter","year":"2025","journal-title":"Neoplasia"},{"key":"B197","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/tub-230002","article-title":"Co-expression of galectin-3 and vimentin in triple negative breast cancer cells promotes tumor progression, metastasis and survival","volume":"45","author":"Jeethy Ram","year":"2023","journal-title":"Tumour Biol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001391","article-title":"Galectin-9-based immune risk score model helps to predict relapse in stage I-III small cell lung cancer","volume":"8","author":"Chen","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B199","doi-asserted-by":"publisher","first-page":"31229","DOI":"10.1038\/s41598-025-15310-3","article-title":"Circulating galectin-9 as a novel prognosticator in patients with intrahepatic cholangiocarcinoma undergoing surgical resection","volume":"15","author":"Kurimoto","year":"2025","journal-title":"Sci Rep"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153809","article-title":"Pattern analysis of serum galectins-1, -3, and -9 in breast cancer","volume":"15","author":"Funkhouser","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040953","article-title":"High galectin-7 and low galectin-8 expression and the combination of both are negative prognosticators for breast cancer patients","volume":"12","author":"Trebo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.149184","article-title":"Serum galectin-9 mirrors immune-evasive microenvironment and predicts early recurrence in hepatocellular carcinoma","volume":"942","author":"Wenjing","year":"2025","journal-title":"Gene"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8031328","article-title":"Fecal galectin-3: A new promising biomarker for severity and progression of colorectal carcinoma","volume":"2018","author":"Jovanovic","year":"2018","journal-title":"Mediators Inflammation"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4824813","article-title":"Elevated soluble galectin-3 as a marker of chemotherapy efficacy in breast cancer patients: A prospective study","volume":"2020","author":"Shafiq","year":"2020","journal-title":"Int J Breast Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1849406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:04:45Z","timestamp":1784095485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1849406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":204,"alternative-id":["10.3389\/fimmu.2026.1849406"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1849406","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1849406"}}